Screener
ADMA Biologics ADMA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
FAQ
- What is ADMA Biologics's free cash flow?
- ADMA Biologics (ADMA) reported free cash flow of $27.28M in Q2 2026.
- How has ADMA Biologics's free cash flow changed year-over-year?
- ADMA Biologics's free cash flow increased by 45.8% year-over-year, from $18.72M to $27.28M.
- What is the long-term trend for ADMA Biologics's free cash flow?
- Over 4 years (2021 to 2025), ADMA Biologics's free cash flow has grown at a -31.4% compound annual growth rate (CAGR), from -$125.88M to $27.82M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about ADMA Biologics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude